CURANUM AG

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
-------------------------------------------------------------------------------- 

Company Information/Changes to the Chairmanship of the Management Board of CURANUM AG

03.09.2010

Unscheduled announcement

Changes to the Chairmanship of the Management Board of CURANUM AG

CURANUM AG, Munich, announces that the Supervisory Board has today removed Mr. Bernd Rothe from his position as Chairman of the Management Board (CEO), and has also removed him from the Management Board with immediate effect, as well as relieving him from all duties within the Group.

The Supervisory Board plans to appoint and announce his successor within the next weeks. Until then, Mr. Rothe's duties will be exercised by Management Board members Mrs. Judith Barth (CFO) and Mrs. Sabine Weirich (COO).

Munich, September 3, 2010

The Management Board

end of announcement                               euro adhoc
-------------------------------------------------------------------------------- 

Further inquiry note:

Bettina Pöschl
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN:    DE0005240709
WKN:     524070
Index:   CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurt / regulated dealing/prime standard
         Berlin / free trade
         Hamburg / free trade
         Stuttgart / free trade
         Düsseldorf / free trade
         München / regulated dealing